PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21381053-6	2012	Trolox prevented the release of receptor activator of nuclear factor-kappaB ligand (RANKL), IL-6, and TNF-alpha induced by AMA.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	0-6	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	32-82	
24929117-8	2014	In addition, Trolox suppressed RANKL expression in osteoblasts induced by soluble factors from 4T1 cells.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	13-19	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	31-36	
21381053-6	2012	Trolox prevented the release of receptor activator of nuclear factor-kappaB ligand (RANKL), IL-6, and TNF-alpha induced by AMA.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	0-6	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	84-89	
19299513-0	2009	Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	0-6	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	50-55	
19299513-4	2009	Trolox potently inhibited interleukin-1-induced osteoclast formation in bone marrow cell-osteoblast coculture by abrogating RANKL induction in osteoblasts.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	0-6	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	124-129	
19299513-6	2009	We also found that Trolox inhibited osteoclast formation from bone marrow macrophages induced by macrophage colony-stimulating factor plus RANKL in a reversible manner.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	19-25	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	139-144	
19299513-9	2009	We found that Trolox down-regulated the induction by RANKL of c-Fos protein by suppressing its translation.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	14-20	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	53-58	
19299513-12	2009	Taken together, our findings indicate that Trolox prevents osteoclast formation and bone loss by inhibiting both RANKL induction in osteoblasts and c-Fos expression in osteoclast precursors.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	43-49	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	113-118